<DOC>
	<DOCNO>NCT01802359</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness mirodenafil participant erectile dysfunction .</brief_summary>
	<brief_title>A Study Evaluate Safety Effectiveness Mirodenafil Korean Patients With Erectile Dysfunction</brief_title>
	<detailed_description>This non randomized ( study medication assign chance ) , open-label ( participant study staff know identity treatment ) , multi-center , prospective ( look forward use observation collect follow participant enrollment ) , non-comparative study participant erectile dysfunction observe evaluate safety effectiveness mirodenafil 12 week . Safety evaluation include assessment adverse event , record concomitant medication . The study conduct Korea .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Mirodenafil</mesh_term>
	<criteria>Participants diagnose erectile dysfunction Participants prescribe mirodenafil demand Participants administer mirodenafil approve indication</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Mirodenafil</keyword>
	<keyword>Bravonto</keyword>
</DOC>